Researchers from the University of Toronto have created a shoebox-sized laboratory that can do blood testing in remote, low-resource settings, quickly determining from a drop of blood whether a person has antibodies to specific infectious diseases.
The device, which they called the MR Box—short for measles and rubella, the first diseases for which they tested—is still being fine-tuned. But their hope is that eventually it could be used to test for a variety of diseases, for both outbreak control and research purposes, in parts of the world where conventional lab support is hours—or farther—away, the scientists reported Wednesday.
Device testing was conducted at a refugee camp in Kakuma, Kenya, where pinprick blood samples were examined for antibodies to measles and rubella. But the scientists behind the work said future versions of the mini-lab could be used to test for antibodies to other pathogens and also for the pathogens themselves.
Antibody testing is used to see if someone has been previously infected with, or vaccinated against, a disease agent. Being able to use a test like this to look for who has a targeted disease agent in their blood would help people responding to an outbreak know who was infected and who wasn’t.
“That is the dream, that this type of system with its flexibility could be sent out into the world and really be used very flexibly depending on the conditions on the ground,” said senior author Aaron Wheeler, who leads the lab in which the work was done.
The paper, which also had authors from the Kenyan ministry of health and the Centers for Disease Control and Prevention, was published in the journal Science Translational Medicine.
Omicron subvariant BA.2 replicates faster in brain cells than other strains, study finds
Omicron subvariant BA.2 – which was dominant worldwide early this year, including in Hong Kong – replicates more swiftly than other strains and causes faster programmed cell death in human brains, a new study has found. [...]
Seeding the oceans with iron-rich fertilizer nanoparticles to store excess carbon dioxide
The urgent need to remove excess carbon dioxide from Earth’s environment could include enlisting some of our planet’s smallest inhabitants, according to an international research team led by Michael Hochella of the Department of [...]
Temporary graphene ‘tattoos’ that measure blood pressure
Blood pressure is a key vital sign that provides insight into our cardiovascular health. But blood pressure is typically measured only a few times per year by a clinician—and these measurements might not always [...]
Next Covid-19 Strain May be More Dangerous, Lab Study Shows
A South African laboratory study using Covid-19 samples from an immunosupressed individual over six months showed that the virus evolved to become more pathogenic, indicating that a new variant could cause worse illness than [...]
The Fast-Spreading New COVID-19 Subvariant XBB Is Part of a ‘New Class’ of Omicron
For the past several months, Omicron subvariants BA.4 and BA.5 have dominated COVID-19 cases in the U.S. But now, there’s a class of new COVID subvariants on the rise and one in particular is getting plenty of [...]
Overcoming challenges in the delivery of nucleic acid therapeutics
Nucleic acid therapies involving DNA or RNA have significant potential to treat genetic disorders, infectious diseases, and cancer; however, research suggests that less than 1% of injected nucleic acid doses reach target cells in [...]
FDA approves $3.5 million treatment for hemophilia, now the most expensive drug in the world
The US Food and Drug Administration on Tuesday approved Hemgenix, a new drug to treat hemophilia. Manufacturer CSL Behring set the price at $3.5 million per treatment, making it the most expensive drug [...]
Wireless smart bandage promotes faster closure of wounds, enhances skin recovery
Some wounds just won’t heal. Infections, diseases like diabetes, and suppressed immune systems often stack up to slow healing. Chronic wounds can last months and lead to anxiety and depression. In the worst cases, [...]
Leave A Comment